Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€117.20

€117.20

-0.310%
-0.36
-0.310%
€127.60
 
06.06.25 / Tradegate WKN: 850103 / Symbol: ABT / Name: Abbott / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Abbott Laboratories is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Abbott

sharewise wants to provide you with the best news and tools for Abbott, so we directly link to the best financial data sources.

News

Tariff-Resistant Abbott Laboratories on Track for New Highs: https://www.marketbeat.com/logos/articles/med_20250416103940_chart-abt-4162025.png
Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories (NYSE: ABT) is not immune to the impact of tariffs on its medical device business. However, the company’s diversified business is tariff-resistant, and moves are being made to

Abbott Laboratories Stock: CE Mark Boosts Cardiac Treatment Innovation
Abbott Laboratories Stock: CE Mark Boosts Cardiac Treatment Innovation

Abbott Laboratories recently experienced a significant upward breakthrough after receiving CE marking for its innovative Volt PFA system, designed to treat atrial fibrillation. This heart rhythm

Abbott Laboratories Stock: Executives Sell Shares Near 52-Week High
Abbott Laboratories Stock: Executives Sell Shares Near 52-Week High

Abbott Laboratories is experiencing notable stock market activity as multiple senior executives recently divested portions of their holdings. Former Executive Vice President Andrea F. Wainer sold

Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Abbott Laboratories Will Outperform Healthcare Stocks in 2025

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott

2 Dividend Stocks to Buy With $500 and Hold Forever: https://g.foolcdn.com/editorial/images/818808/pet-owners-walking-their-dog.jpg
2 Dividend Stocks to Buy With $500 and Hold Forever

Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?: https://g.foolcdn.com/editorial/images/816660/person-drinking-bottled-drink-with-a-straw.jpg
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?

Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those

3 Dividend Stocks to Buy and Hold for the Next Decade: https://g.foolcdn.com/editorial/images/816017/person-smiling-and-looking-at-laptop.jpg
3 Dividend Stocks to Buy and Hold for the Next Decade

Many income investors would love to have a low-maintenance portfolio that doesn't require constant attention. They'd prefer to buy great stocks and rake in the dividends without any hiccups.

Three

3 Relatively Safe Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/812763/woman-with-fingers-crossed-laptop.jpg
3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions.

Three Motley Fool contributors think

Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday: https://g.foolcdn.com/editorial/images/812838/two-people-participating-in-a-telehealth-session.jpg
Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a

2 Unstoppable Dividend Stocks That Will Pay You for Life
2 Unstoppable Dividend Stocks That Will Pay You for Life

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As most income seekers want to avoid this fate, they might consider turning to

Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.

Abbott Laboratories (NYSE: ABT)Q4 2024 Earnings CallJan 22, 2025, 9:30 a.m. ET

Operator

Continue reading

Source Fool.com